SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
2.120
0.00 (0.00%)
At close: Sep 12, 2025, 4:00 PM EDT
2.100
-0.020 (-0.94%)
After-hours: Sep 12, 2025, 7:57 PM EDT
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $22.07 million as of September 12, 2025. Its market cap has decreased by -4.97% in one year.
Market Cap
22.07M
Enterprise Value
22.78M
1-Year Change
-4.97%
Ranking
Category
Stock Price
$2.12
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has decreased from $130.75M to $22.07M, a decrease of -83.12%. That is a compound annual growth rate of -32.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 22.07M | -36.97% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
| Feb 9, 2021 | 130.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |